secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2023-10-18T23:59:59+00:00
Accession:  0001193125-23-258013
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health Q3 adj. EPS $8.99, revenue $42.5B (+7.2%); raises FY23 guidance
-------------------------------------------------------------------------------

- GAAP EPS $5.45 includes $3.54/share net negative items; adjusted EPS $8.99.
- Operating revenue $42.5B, up 7.2% YoY; benefit expense ratio improved 40 bps to 86.8%.
- Medical membership 47.3M, down 664K sequentially due to Medicaid redeterminations and competitor entry.
- Company raises FY2023 guidance: GAAP EPS >$26.40, adjusted EPS >$33.00.
- Q3 includes $697M business optimization charge; operating cash flow $2.6B, 2.0x net income.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000119312523258013/0001193125-23-258013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000119312523258013/d568311d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-258013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer